Monday, October 3, 2022

561.316.3330

Biotechnology News Magazine

Aquestive Therapeutics Announces Leadership Transition of Chief Financial Officer

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today announced that A. Ernest (Ernie) Toth, Jr., a seasoned financial executive and currently serving the Company as the interim Chief Financial Officer, has transitioned to the permanent role of Senior Vice President and Chief Financial Officer effective immediately.

“Ernie is a seasoned and experienced financial executive. He has become a valued member of our team and an important part of our external relationships in the financial community. We look forward to the effective leadership of the financial functions of the Company that Ernie will bring,” said Keith Kendall, Director, President and Chief Executive Officer of Aquestive.

Ernie Toth joined Aquestive as Interim CFO in December 2020 through the services of Danforth Advisors, a consulting firm providing finance support and strategic advisory services to life science companies and the healthcare technology industry. Prior to joining Aquestive, Mr. Toth was CFO of EHE Health, a national preventive health, primary care, and telehealth network owned by Summit Partners and DW Healthcare Partners.

From January, 2016 to December, 2016, Mr. Toth was Chief Financial Officer of ArisGlobal, an end-to-end drug development platform, and from January, 2015 to December, 2015, he served as Global Chief Financial Officer of Synowledge, a global life sciences solutions company providing drug safety, regulatory affairs and IT services to diverse pharmaceutical, biotechnology and medical devices companies. Owned by the Abbhi family, at both ArisGlobal and Synowledge, he led Finance, HR, IT, Legal, and Commercial Operations during periods of high growth and the sale of Synowledge to Bioclinica.

Mr. Toth was Chief Financial Officer from 2011 to 2013 of JHP Pharmaceuticals, a PE owned (Morgan Stanley Private Investments) integrated specialty healthcare company that develops, manufactures and sells branded and generic aseptic injectable pharmaceuticals and provides contract manufacturing services for global pharmaceutical companies. As CFO, Mr. Toth provided financial and operational leadership through 9 new product launches, 17 ANDA filings, a BARDA award, clinical trials and the sale to Warburg Pincus in 2012.

From 2014 until its sale to a strategic buyer in 2017, Mr. Toth was a member of the Board of Directors of Eska, a leading Canadian beverage company owned by Morgan Stanley Private Investments. Mr. Toth’s prior experience includes senior financial leadership positions at Valeritas, Pharmaceutical Formulations, and World Power Technologies. He spent 15 years in various financial positions at MacAndrews & Forbes, the investment company owned by Ronald O. Perelman.

Mr. Toth holds an MBA from Pace University, a BS in Accounting from Shippensburg University of Pennsylvania, and is a CPA in the State of New York.

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine